Luis Escobar-López

685 total citations
6 papers, 106 citations indexed

About

Luis Escobar-López is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Luis Escobar-López has authored 6 papers receiving a total of 106 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Rheumatology and 1 paper in Molecular Biology. Recurrent topics in Luis Escobar-López's work include Viral Infections and Immunology Research (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Luis Escobar-López is often cited by papers focused on Viral Infections and Immunology Research (3 papers), Cardiomyopathy and Myosin Studies (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Luis Escobar-López collaborates with scholars based in Spain, United States and Netherlands. Luis Escobar-López's co-authors include Ricardo O. Escárcega, Salvador Fuentes-Alexandro, Pablo García‐Pavía, Jorge Rojas-Rodríguez, Mario García‐Carrasco, Han G. Brunner, Kasper Derks, Arthur van den Wijngaard, Gianfranco Sinagra and Marco Masè and has published in prestigious journals such as European Heart Journal, Journal of Medical Genetics and Joint Bone Spine.

In The Last Decade

Luis Escobar-López

6 papers receiving 106 citations

Peers

Countries citing papers authored by Luis Escobar-López

Since Specialization

Citations

This map shows the geographic impact of Luis Escobar-López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Escobar-López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Escobar-López more than expected).

Fields of papers citing papers by Luis Escobar-López

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Escobar-López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Escobar-López. The network helps show where Luis Escobar-López may publish in the future.

Co-authorship network of co-authors of Luis Escobar-López

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Escobar-López. A scholar is included among the top collaborators of Luis Escobar-López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Escobar-López. Luis Escobar-López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Clinical management and healthcare resource utilization among patients with obstructive hypertrophic cardiomyopathy in Spain: a real-world study 2025 ·Revista Española de Cardiología (English Edition) ·Roberto Barriales‐Villa, Luis Escobar-López, (unknown), Joel Salazar‐Mendiguchía, (unknown), (unknown), (unknown), Juan R. Gimeno	1
2	Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers 2023 ·Journal of Medical Genetics ·Jesús Piqueras‐Flores, Eduardo Villacorta, Joseph Galvin, Vicente Climent, Luis Escobar-López, Almudena Amor‐Salamanca, Soledad García-Hernández, (unknown), (unknown), (unknown), Pablo García‐Pavía, Juan Pablo Ochoa	2
3	Endomyocardial biopsy-confirmed myocarditis and inflammatory cardiomyopathy: clinical profile and prognosis 2022 ·Revista Española de Cardiología (English Edition) ·Fernándo Domínguez, Rafael Cobas Paz, Clara Salas, (unknown), J. Domínguez, Luis Escobar-López, Fernando de Frutos, Marta Cobo Marcos, Esther González-López, Francisco José Hernández-Pérez, Cristina Mitroi, (unknown), Mercedes Rivas‐Lasarte, Manuel Gómez‐Bueno, Pablo García‐Pavía, Javier Segovia	6
4	Miocarditis y miocardiopatía inflamatoria confirmadas por biopsia endomiocárdica: perfil clínico y pronóstico 2022 ·Revista Española de Cardiología ·Fernándo Domínguez, Rafael Cobas Paz, Clara Salas, (unknown), J. Domínguez, Luis Escobar-López, Fernando de Frutos, Marta Cobo Marcos, Esther González-López, Francisco José Hernández-Pérez, Cristina Mitroi, (unknown), Mercedes Rivas‐Lasarte, Manuel Gómez‐Bueno, Pablo García‐Pavía, Javier Segovia	1
5	Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences 2020 ·European Heart Journal ·Job A.J. Verdonschot, Marco Merlo, Fernándo Domínguez, Ping Wang, Michiel T.H.M. Henkens, Michiel Adriaens, Mark R. Hazebroek, Marco Masè, Luis Escobar-López, Rafael Cobas Paz, Kasper Derks, Arthur van den Wijngaard, Ingrid P.C. Krapels, Han G. Brunner, Gianfranco Sinagra, Pablo García‐Pavía, Stéphane Heymans	69
6	Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis 2007 ·Joint Bone Spine ·Mario García‐Carrasco, Salvador Fuentes-Alexandro, Ricardo O. Escárcega, Jorge Rojas-Rodríguez, Luis Escobar-López	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact